About the Consortium

​

Medical Impact Ventures (MIV) developed a consortium of renowned organizations in sarcoma and orthopedic oncology surgery centers that manage TGCT, DFW Sarcoma Center, Thomas Jefferson Musculoskeletal Oncology Center, Fox Chase Cancer Centers, the Rothman Orthopaedic Institute, and UC Davis Comprehensive Cancer Center. MIV's approach includes leveraging these organizations’ respective familiarity with the practical application of translational research to elucidate optimal approaches to patient-centered treatment and maintenance, including combination approaches for medication and surgery and close knowledge, practice, and care gaps.